Mateusz Gliwiński

Toward Male Individualization with Rapidly Mutating Y-Chromosomal Short Tandem Repeats

Kaye N. Ballantyne, Arwin Ralf, Rachid Aboukhalid et al. · Human Mutation · 2014 · 193 citations · Full text

Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

Natalia Marek-Trzonkowska, Małgorzata Myśliwiec, Dorota Iwaszkiewicz‐Grześ et al. · Journal of Translational Medicine · 2016 · 99 citations · Full text

Administration of CD4+CD25highCD127−FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study

Kamil Chwojnicki, Dorota Iwaszkiewicz‐Grześ, Anna Jankowska et al. · BioDrugs · 2021 · 63 citations

Cell Therapy, Relapsing-remitting Multiple Sclerosis, Autoimmune Disease +13

Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization

Anke Fuchs, Mateusz Gliwiński, Nathali Grageda et al. · Frontiers in Immunology · 2018 · 55 citations · Full text

Combined therapy with <scp>CD4</scp> ⁺ <scp>CD25highCD127</scp> ⁻ T regulatory cells and <scp>anti‐CD20</scp> antibody in recent‐onset type 1 diabetes is superior to monotherapy: Randomized phase I/ <scp>II</scp> trial

Maciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz‐Grześ et al. · Diabetes Obesity and Metabolism · 2022 · 47 citations